Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$372K Sell
1,477
-240
-14% -$51.6K 0.06% 56
2026
Q1
$373K Sell
1,717
-382
-18% -$84.7K 0.07% 45
2025
Q4
$480K Buy
2,099
+262
+14% +$59.7K 0.08% 36
2025
Q3
$425K Buy
1,837
+205
+13% +$41.7K 0.08% 39
2025
Q2
$303K Buy
+1,632
New +$303K 0.06% 49

Other funds holding ABBV

New World Advisors's ABBV Position: Q2 2026 in Review

New World Advisors reduced its AbbVie (ABBV) stake by 14% in Q2 2026, selling an estimated $51.6K and leaving 1,477 shares worth $372K. The position accounts for 0.06% of the portfolio, ranked #56.

New World Advisors first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. The position peaked at $480K in Q4 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • New World Advisors held 1,477 shares of AbbVie worth $372K as of Q2 2026.
  • New World Advisors sold 240 AbbVie shares in Q2 2026, an estimated $51.6K.
  • AbbVie made up 0.06% of New World Advisors's portfolio in Q2 2026, its #56 holding.
  • New World Advisors first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • New World Advisors's AbbVie position peaked at $480K in Q4 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on New World Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.